Showing 3201-3210 of 4262 results for "".
- SGR Patch: AADA Disappointed By Congressional Actionhttps://practicaldermatology.com/news/20140401-sgr_patch_aada_disappointed_by_congressional_action/2459285/Statement from Brett M. Coldiron, MD, FAAD President, American Academy of Dermatology Association: The U.S. House of Representatives and Senate have averted a 24 percent cut in Medicare physician payments by agreeing to a one-year short-term measure (HR 4302) to maintain current Medicare payment r
- Novartis Announces EU Approval of Xolair for Chronic Spontaneous Urticaria Patients Unresponsive to Antihistamineshttps://practicaldermatology.com/news/20140307-novartis_announces_eu_approval_of_xolair_for_chronic_spontaneous_urticaria_patients_unresponsive_to_antihistamines/2459322/
- New Stelara Data Show Inhibition Of Joint Destruction In Psoriatic Arthritis Patientshttps://practicaldermatology.com/news/20131029-new_stelara_data_show_inhibition_of_joint_destruction_in_psoriatic_arthritis_patients/2459427/New findings from two integrated Phase III Janssen Research & Development, LLC (Janssen)-sponsored studies showed treatment with ustekinumab (Stelara) resulted in
- FDA Files sBLA for Xolair in Patients with Chronic Idiopathic Urticariahttps://practicaldermatology.com/news/20131011-genentech_files_sbla_for_xoliar_in_patients_with_cronic_idiopathic_urticaria/2459437/The FDA accepted and filed Genentech's supplemental Biologics License Application (sBLA) for subcutaneous use of Xolair® (omalizumab) in people with Chronic Idiopathic Urticaria (CIU) who remained symptomatic despite treatment with H1-antihistamine therapy at approved doses. The filing was primarily
- Modernizing Medicine and Miraca Life Sciences Partner to Create Enhanced EMR and Pathology Lab Integrationhttps://practicaldermatology.com/news/20130926-modernizing_medicine_and_miraca_life_sciences_partner_to_create_enhanced_emr_and_pathology_lab_integration/2459448/
- Rosacea Concierge Offers Patient Support and Resourceshttps://practicaldermatology.com/news/20130924-rosacea_concierge_offers_patient_support_and_resources/2459453/Bayer HealthCare recently launched Rosacea Concierge, a new resource for the estimated 16 million people living with rosacea. The new, easy-to-navigate www.RosaceaConcierge.com includes information on rosacea in the form of video tutorials from a team of experts, including a der
- Do Physicians Mention Sunscreen Use Often Enough at Patient Visits?https://practicaldermatology.com/news/20130905-do_physicians_mention_sunscreen_use_often_enough_at_patient_visits/2459468/
- ASDS Reports High Patient Satisfaction with Soft Tissue Filler Procedureshttps://practicaldermatology.com/news/20130729-asds_reports_high_patient_satisfaction_with_soft_tissue_filler_procedures/2459490/Dermal filler treatments are among the highest rated in consumer satisfaction, according to survey data released by the American Society for Dermatologic Surgery. The ASDS Consumer Survey on Cosmetic Dermatologic Procedures asked more than 6,300 consumers for their opinions on cosmetic treatments in
- Novan Therapeutics Presents Data for Potential Topical Agent that Reduces Sebum in Acne Patientshttps://practicaldermatology.com/news/20130228-novan_therapeutics_presents_data_for_potential_topical_agent_that_reduces_sebum_in_acne_patients/2459602/Recent in vitro and animal testing data from Novan Therapeutics indicate that the company's drug candidate, SB204, could lead to a topical treatment for acne that reduces oil production in the skin. Dr. Diane Thiboutot, Professor of Dermatology at Penn State Hershey College of Medicine, notes that,
- Plastic Surgeons Use ExtendCredit to Provide Financing Services for Patientshttps://practicaldermatology.com/news/20120830-plastic_surgeons_use_extendcredit_to_provide_financing_services_for_patients/2459744/Riverside Plastic Surgery and San Diego-based SpiritLift Plastic Surgery recently started using ExtendCredit.com, an online software platform for creating and managing in-house customer financing plans for small to mid-sized businesses. The two practices now use ExtendCredit's fully automated, onlin